Infranix hexa

Infantrix hexa is prescribed for primary immunization for the prevention of hepatitis B, tetanus, diphtheria, whooping cough, infection caused by a hemophilic stick ( Pfeyfer's stick ) type b in infants (up to six weeks) and poliomyelitis. The vaccine can also be given to infants who received the first preventive dose from hepatitis B at birth.

The drug "Infanrix hexa" is injected deep into the lateral muscle into the upper or middle thigh area in the anterolateral area.

Before use, the suspension is shaken thoroughly until a homogeneous, cloudy white slurry is obtained. The lyophilized precipitate (dry) and the suspension should be visually checked for changes in physical properties or the presence of any foreign particles. If changes in the properties are noted or uncharacteristic particles appear, the drug can not be used. The vaccine must be disposed of.

Infantix hexa is prepared by adding all the contained suspension in a syringe into a container (vial) with a lyophilized powder. If a normal vial and a syringe are included in the kit, after the suspension has been transferred to powder, the mixture must be thoroughly and gently shaken until the lyophilizate is completely dissolved.

Ready vaccine "Infanrix hexa" is recruited in the same syringe. Then the needle is removed and replaced with a new one.

If a bottle with a Bioset cap is included with the syringe, the powder becomes available after scrolling and removing the coating. The container with the suspension (syringe) is fixed with a light push on the Bioset. Clicking will indicate the activation of the system. Mud slurry is injected into the lyophilizate (powder). The vial should be carefully, but gently shaken, holding the syringe. After completely dissolving the precipitate, the mixture is drawn into the syringe. After that, the needle is attached to the injection.

The vaccine looks more cloudy than the suspension to dissolve the powder or solution. This is the norm. If any other changes are detected, the drug is not used.

The vaccine is administered immediately after preparation.

The drug is contraindicated in patients with hypersensitivity to any component or to those with high sensitivity reactions after previous vaccination. A remedy is not used if the child previously had an encephalopathy of unclear etiology within a week after the last injection of pertussis ingredient-containing vaccines. In such cases, the vaccination course continues for the prevention of tetanus, diphtheria, hemophilic rod, hepatitis B vaccine inactivated poliomyelitis. The vaccination against pertussis is stopped.

The most common in medical practice after primary vaccination are the following side effects: hyperemia, pain, swelling, fever, irritability, drowsiness, anorexia. In extremely rare cases, anaphylactoid reaction to drugs containing DTPa (IPR infarix) can be noted. The use of vaccines with a pertussis ingredient can cause a shock-like condition or collapse and seizures for two to three days after the injection. In clinical practice, these cases were extremely rare. In this case, all patients after such reactions recovered without complications.

When vaccinated with the drug "Infarriks" reviews in most cases, positive. Indeed, parents generally do not notice any side effects in children. Sometimes there is soreness at the injection site. As a rule, vaccinations are transferred well. The resulting undesirable consequences are eliminated without particular difficulties. Some pediatricians admit that they have never seen children with side effects after the infarix.